Screener
Enovis ENOV Prevention & Recovery — Operating Costs and Expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Enovis in its filing.
Tagged under the XBRL concept us-gaap:OperatingCostsAndExpenses.
The source filing: Enovis’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001420800-26-000035
| Line item | Three Months Ended / July 3, 2026 | Three Months Ended / July 4, 2025 | Six Months Ended / July 3, 2026 | Six Months Ended / July 4, 2025 |
|---|---|---|---|---|
| Segment cost of sales | 124,094 | 131,336 | 249,851 | 260,100 |
| Segment research and development | 7,706 | 9,669 | 15,453 | 18,910 |
| Segment operating expense | 111,250 | 107,523 | 223,720 | 215,367 |
| Total segment expenses | 243,050 | 248,528 | 489,024 | 494,377 |
| Add: Depreciation | 5,129 | 4,689 | 10,194 | 8,857 |
| Adjusted EBITDA (non-GAAP) | $50,327 | $46,731 | $81,436 | $77,634 |
| Reconstructive: | ||||
| Net sales | $294,534 | $273,975 | $611,667 | $560,225 |
Item 1. Financial Statements
FAQ
- What is Enovis's prevention & recovery — operating costs and expenses?
- Enovis (ENOV) reported prevention & recovery — operating costs and expenses of $243.05M in Q2 2026.
- What does prevention & recovery — operating costs and expenses mean?
- This metric represents the total operating costs and expenses incurred by the Prevention & Recovery segment, which focuses on rehabilitation, pain management, and physical therapy devices. It encompasses all direct and indirect costs associated with the production, distribution, and administration of products within this specific business unit. Monitoring this figure helps investors assess the operational efficiency and cost structure of the segment relative to its revenue generation.
Ask your AI about Enovis's prevention & recovery — operating costs and expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude